Arbutus Biopharma Corporation (ABUS) rose 12.64% or 1.15 to $10.25. It is nearly 1.66 million shares traded, which is 459.66% compare to the average total volume 360963. The market cap of ABUS is $567.89 million. The year to date change is 79.61%. The 52 week price range is from $4.12 to $12.6. Price of ABUS have changed 0.55% during last week. It have changed -20.87% over last month, 56.90% over last 3 months, 73.33% over last 6 months and 149.32% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ABUS is 9.58. It is -6.54% below current price. The 200-day Moving Averages for ABUS is 6.51. It is -36.49% below current price. The 52-week High is 12.6. It is 22.93% from the current price. The 52-week Low is 4.12. It is -59.80% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ABUS is 5.2 on 2018-08-15. Short % to float is 4.81%. There are some statistics of ABUS. It is has market cap $567.89 million. The share outstanding is 55.40 million. The average volume is 360963. The revenue is 6.89M. The gross profit is -8645000. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ABUS is -46.19%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ABUS is -25.43%.